Status
Conditions
About
Background:
Objective:
Eligibility:
Design:
Full description
Lifestyle interventions can result in weight loss, but most people experience a plateau after 6-10 months when weight stabilizes and many subsequently regain weight over the subsequent months. This pattern of weight plateau and regain is typical and appears to be independent of the lifestyle intervention used. The apparent resistance to further weight loss in not well understood.
We recently demonstrated that participants engaged in an intensive intervention employing caloric restriction and vigorous exercise had a profound slowing of metabolism that was significantly greater than expected due to weight loss alone. This phenomenon is called metabolic adaptation and has also been observed following weight loss through caloric restriction without exercise and may persist long after weight loss has ceased. Metabolic adaptation has been hypothesized to limit weight loss and predispose individuals to weight regain, but this has yet to be demonstrated and the concept is controversial. In addition to the metabolic adaptations to weight loss, the brain also adapts in ways that enhance the activation of reward regions in response to palatable food cues and their receipt. In particular, the brain s dopamine circuitry is believed to be altered in obesity and it is presently unclear how this pathway responds to a weight loss intervention in humans.
The primary aims of this study are to investigate the metabolic and neural adaptations in 60 obese adult volunteers participating in lifestyle interventions resulting in weight loss through a structured meal replacement program or caloric restriction plus vigorous exercise. The secondary aim is to determine whether the magnitude of metabolic adaptation or the changes in the brain s reward circuitry or responsiveness to food cues are related to the ubiquitous weight loss plateau after 6-10 months or the rate of weight regain in the subsequent months.
Sex
Ages
Volunteers
Inclusion and exclusion criteria
EXCLUSION CRITERIA:
Body weight > 400 lbs (weight limit of PET and MRI scanners)
BMI < 30 kg/m2
Less than 80% of maximum lifetime weight
Hypertension if
Evidence of metabolic or cardiovascular disease, or disease that may influence metabolism (e.g. cancer, thyroid disease)
Past or present history of eating disorder (including binge eating) or psychiatric disease
Taking any prescription medication or other drug that may influence metabolism (e.g. diet/weight-loss medication, asthma medication, psychiatric medications, corticosteroids, or other medications at the discretion of the PI and/or study team)
Hematocrit < 34% (women only)
Hematocrit < 40% (men only)
Pregnancy, lactation (women only)
Women who become pregnant during the two-year study period
Recent participation in a regular exercise program (> 4h/week of vigorous activity)
Previous bariatric surgery
Caffeine consumption > 500 mg/day
Regular use of alcohol (>2 drinks per day), tobacco (smoking or chewing) amphetamines, cocaine, heroin, or marijuana over past 6 months
Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, multiple food allergies)
Having metal implants incompatible with MRI (for example, pacemakers, metallic prostheses such as cochlear implants or heart valves, shrapnel fragments, etc.).
Non-native English speakers
Volunteers unwilling or unable to give informed consent
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal